Information on AIADK

Basic details

Name: Autoinflammation with arthritis and dyskeratosis | Acronym: AIADK
Alt. names: NLRP1 deficiency

Gene: NLRP1 | MOI: Autosomal recessive | Mechanism of action:

No. of cases in DB: 0 | First reported in: 2016

Last updated on: 2023-02-28 16:41:18 by

OMIM: 617388

Orphanet: -

MONDO: -

DOID: -

ClinGen:

Description

Palmoplantar carcinoma involves recurrent palmoplantar, conjunctival, and corneal keratoacanthomas, and individuals have been described as having high susceptibility to malignant squamous cell carcinoma; Features of Autoinflammation with arthritis and dyskeratosis have been described as including anemia severe enough to necessitate splenectomy, and awareness may allow prompt diagnosis and management; Individuals were not reported to benefit from Vitamin A supplementation. Refs. PMIDs: 23349227; 27662089; 27965258

Management

Description of management option has not been reviewed yet.

Please mind that full curation of this condition has not started yet. Please contact us if you want to volunteer.

0 reported cases added to GenIA

SubjectID Sex Fam.ID AD AFM Validity Country Population Reference & Pub.code

AD: Age at genetic diagnosis; AFM: age at first manifestation; PMID: PubMed ID; GRID: GenIA reference ID (ref. not in PubMed).

Summary of clinical findings

[Considering only Definitive and Possible cases]

Rank Clinical term Present Absent Unreported
1 Elevated C-reactive proteinarrow icon 3 (99.9%) 0 (0.0%) 0 (0.0%)
2 Follicular hyperkeratosisarrow icon 3 (99.9%) 0 (0.0%) 0 (0.0%)
3 Infantile onsetarrow icon 3 (99.9%) 0 (0.0%) 0 (0.0%)
4 Palmoplantar hyperkeratosisarrow icon 3 (99.9%) 0 (0.0%) 0 (0.0%)
5 Polyarthritisarrow icon 3 (99.9%) 0 (0.0%) 0 (0.0%)
6 Recurrent feversarrow icon 3 (99.9%) 0 (0.0%) 0 (0.0%)
7 Antinuclear antibodiesarrow icon 2 (66.7%) 0 (0.0%) 1 (33.3%)
8 Growth delayarrow icon 2 (66.7%) 0 (0.0%) 1 (33.3%)
9 Autoimmune hemolytic anemiaarrow icon 1 (33.3%) 0 (0.0%) 2 (66.7%)
10 Corneal neovascularizationarrow icon 1 (33.3%) 0 (0.0%) 2 (66.7%)
11 Dry skinarrow icon 1 (33.3%) 0 (0.0%) 2 (66.7%)
12 Failure to thrivearrow icon 1 (33.3%) 0 (0.0%) 2 (66.7%)
13 Hepatomegalyarrow icon 1 (33.3%) 0 (0.0%) 2 (66.7%)
14 Hypereosinophiliaarrow icon 1 (33.3%) 0 (0.0%) 2 (66.7%)
15 Increased IgA levelsarrow icon 1 (33.3%) 0 (0.0%) 2 (66.7%)
16 Increased IgG levelarrow icon 1 (33.3%) 0 (0.0%) 2 (66.7%)
17 Keratoconjunctivitis siccaarrow icon 1 (33.3%) 0 (0.0%) 2 (66.7%)
18 Laryngeal papillomaarrow icon 1 (33.3%) 0 (0.0%) 2 (66.7%)
19 Photophobiaarrow icon 1 (33.3%) 0 (0.0%) 2 (66.7%)
20 Punctate keratitisarrow icon 1 (33.3%) 0 (0.0%) 2 (66.7%)
21 Splenomegalyarrow icon 1 (33.3%) 0 (0.0%) 2 (66.7%)
22 Thyroiditisarrow icon 1 (33.3%) 0 (0.0%) 2 (66.7%)
23 Uveitisarrow icon 1 (33.3%) 0 (0.0%) 2 (66.7%)

Please mind that full curation of this condition has not started yet. Please contact us if you want to volunteer.

Summary of treatment outcomes

[Considering only Definitive and Possible cases]

Treatment ⓘ Responses & clinical indications

Please mind that full curation of this condition has not started yet. Please contact us if you want to volunteer.